Quarterly report pursuant to Section 13 or 15(d)

Segment Information (Tables)

v2.4.0.8
Segment Information (Tables)
 3 Months Ended
Dec. 29, 2013
Notes to Financial Statements [Abstract]  
Revenues and EBT for reportable segments
(in millions):
 
QCT
 
QTL
 
QSI
 
Reconciling
Items*
 
Total
For the three months ended:
 
 
 
 
 
 
 
 
 
December 29, 2013
 
 
 
 
 
 
 
 
 
Revenues
$
4,616

 
$
1,900

 
$
—

 
$
106

 
$
6,622

EBT
906

 
1,670

 
4

 
(823
)
 
1,757

December 30, 2012
 
 
 
 
 
 
 
 
 
Revenues
$
4,120

 
$
1,757

 
$
—

 
$
141

 
$
6,018

EBT
1,068

 
1,532

 
(17
)
 
(256
)
 
2,327


Reconciling items for reportable segments - revenues
Reconciling items in the previous table were as follows (in millions):
 
Three Months Ended
 
December 29,
2013
 
December 30, 2012*
Revenues
 
 
 
Nonreportable segments
$
108

 
$
142

Intersegment eliminations
(2
)
 
(1
)
 
$
106

 
$
141

EBT
 
 
 
Unallocated cost of equipment and services revenues
$
(73
)
 
$
(83
)
Unallocated research and development expenses
(217
)
 
(186
)
Unallocated selling, general and administrative expenses
(125
)
 
(111
)
Unallocated other expense
(12
)
 
—

Unallocated investment income, net
257

 
248

Nonreportable segments
(653
)
 
(124
)
 
$
(823
)
 
$
(256
)

Reconciling items for reportable segments - EBT
Reconciling items in the previous table were as follows (in millions):
 
Three Months Ended
 
December 29,
2013
 
December 30, 2012*
Revenues
 
 
 
Nonreportable segments
$
108

 
$
142

Intersegment eliminations
(2
)
 
(1
)
 
$
106

 
$
141

EBT
 
 
 
Unallocated cost of equipment and services revenues
$
(73
)
 
$
(83
)
Unallocated research and development expenses
(217
)
 
(186
)
Unallocated selling, general and administrative expenses
(125
)
 
(111
)
Unallocated other expense
(12
)
 
—

Unallocated investment income, net
257

 
248

Nonreportable segments
(653
)
 
(124
)
 
$
(823
)
 
$
(256
)

*As adjusted
Nonreportable segments EBT included a total of $460 million in impairment charges related to the Company’s QMT and QRS divisions (Note 9).
Unallocated acquisition-related expenses were comprised as follows (in millions):
 
Three Months Ended
 
December 29,
2013
 
December 30,
2012
Cost of equipment and services revenues
$
61

 
$
63

Research and development expenses
1

 
—

Selling, general and administrative expenses
7

 
7

Segment assets and reconciling items
Segment assets and reconciling items were as follows (in millions):
 
December 29,
2013
 
September 29,
2013
QCT
$
2,292

 
$
3,305

QTL
31

 
28

QSI
474

 
511

Reconciling items
43,485

 
41,672

Total consolidated assets
$
46,282

 
$
45,516